DPP-IV inhibitor

This page covers all DPP-IV inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DPP-4.

Targets

DPP-4

Phase 2 pipeline (1)

• DPP-IV Inhibitor · Hoffmann-La Roche · Diabetes
  DPP-IV inhibitors block the action of dipeptidyl peptidase-4, an enzyme that breaks down incretin hormones, thereby increasing incretin levels and enhancing glucose-dependent insulin secretion.